PTYLTD
    • Insights
    • Videos
  • Pricing
  • About us
  • Contact us
  • Login | Sign up
PTYLTD

Insights

Videos

Pricing

About us

Contact us

  • Home
  • Insights into ASX Stocks
  • By Type

Ocean Sciences (ASX: OSS)

Ocean Sciences (ASX: OSS): Takalar Seaweed Innovation Centre Takes Shape

Oct 7, 2026
Proactive Equities Team

Ocean Sciences (ASX: OSS), formerly BPH Global, has rebranded to reflect its blue economy focus, extended its Takalar site lease and outlined plans for a Seaweed Innovation and Application Centre in Indonesia.

DorsaVi (ASX: DVL)

DorsaVi (ASX: DVL): Physical AI Strategy Targets Humanoid Robotics and Defence

Oct 7, 2026
Proactive Equities Team

DorsaVi (ASX: DVL) is shifting towards Physical AI, combining RRAM technology, human movement data, and strategic funding to advance robotic balance and tactile sensing applications across humanoid robotics and defence.

Weebit Nano (ASX: WBT)

Weebit Nano (ASX: WBT): Fires Back at Bankruptcy Claim, Backed by $168m in Cash

Oct 7, 2026
Proactive Equities Team

Weebit Nano has rejected radio claims that its bankruptcy risk is rising, pointing to a strong cash balance and FY26 capital raisings. It also confirmed an auditor change and its AGM date.

BOA Resources (ASX: BOA)

BOA Resources (ASX: BOA): Strong Copper Results and Technical Momentum Put the Company in Focus

Oct 6, 2026
Proactive Equities Team

BOA Resources has reported strong copper results from Ricci Lee while progressing its Neds Creek consolidation. With further assays pending and shares showing technical momentum, investors will be watching whether ongoing exploration supports a broader copper discovery.

Clarity Pharmaceuticals (ASX: CU6)

Clarity Pharmaceuticals (ASX: CU6): Global Fund Giant Builds 5.25% Stake as Governance Strengthens

Oct 6, 2026
Proactive Equities Team

State Street has disclosed a 5.25% stake in Clarity Pharmaceuticals. Here is what it means for investors, and why a more independent board strengthens the radiopharmaceutical developer's long-term story.

Eden Innovations (ASX: EDE)

Eden Innovations (ASX: EDE): 152% Revenue Jump Shows Concrete Plants Can Build Recurring Sales

Oct 6, 2026
Proactive Equities Team

Eden Innovations' US arm lifted quarterly revenue 152%, powered by OptiBlend dual-fuel kits and EdenCrete additives. A growing network of concrete plants could underpin recurring sales well beyond this quarter.

Proactive Equities

At Proactive Equities, we combine deep market expertise with rigorous analysis to deliver stock recommendations you can trust. Our team of seasoned analysts continuously monitor global markets, economic trends, and company fundamentals to identify high-potential investment and trade opportunities.

Company

Home
Pricing
Contact Us
About Us

Resources

ASX Insights
Investing Basics
Videos

Links

Privacy Policy
Terms and Conditions
Product Disclosure Statement

Proactive Equities Pty Ltd (ACN: 687 232 471) is a Corporate Authorised Representative (AFSR No. 001318293) of Australia National Investment Group Pty Ltd (ABN: 40 636 343 630), which holds an Australian Financial Services Licence (AFSL no. 522028). The information on this website is general information only and does not constitute personal financial advice. We have not taken the individual circumstances, financial objectives or needs of any investor into account when preparing this information. Investors should consider their circumstances and the relevant PDS for any investment and obtain professional financial and tax advice before making any investment decision. The information on this website is not a recommendation to make any investment or to adopt any particular investment strategy. You should make your own professional assessment of the suitability of this information, relying on your own inquiries. Investments in securities are subject to investment risk. Investment value may go down as wellas up, and investors may not get back the full amount originally invested. Risks include: the investment objective may not be achieved, share market and other market risk, liquidity risk, and currency risk with international investments. Any past performance shown is not an indication of future performance. Commission and other costs charged by executing broker are not considered when calculating past performance. To the extent permitted by law Proactive Equities Pty Ltd accepts no liability for any errors or omissions in, or loss from reliance on the information in this website.

1...131415...71
Page 14 of 71